|
1
|
Petty RE, Southwood TR, Manners P, Baum J,
Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J,
Prieur AM, et al: International League of Associations for
Rheumatology classification of juvenile idiopathic arthritis:
Second revision, edmonton, 2001. J Rheumatol. 31:390–392.
2004.PubMed/NCBI
|
|
2
|
Foeldvari I and Bidde M: Validation of the
proposed ILAR classification criteria for juvenile idiopathic
arthritis. International League of associations for rheumatology. J
Rheumatol. 27:1069–1072. 2000.PubMed/NCBI
|
|
3
|
Ravelli A and Martini A: Juvenile
idiopathic arthritis. Lancet. 369:767–778. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peixuan and Xiufen Cheng Hu: Juvenile
idiopathic arthritis and macrophage activation syndrome. J App Clin
Pediatr. 24:1631–1633. 2009.
|
|
5
|
Petty RE, Southwood TR, Baum J, Bhettay E,
Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M,
Orozco-Alcala J and Prieur AM: Revision of the proposed
classification criteria for juvenile idiopathisc arthritis: Durban,
1997. J Rheumatol. 25:1991–1994. 1998.PubMed/NCBI
|
|
6
|
Giancane G, Consolaro A, Lanni S, Davì S,
Schiappapietra B and Ravelli A: Juvenile idiopathic arthritis:
Diagnosis and treatment. Rheumatol Ther. 3:187–207. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee SH, Erber WN, Porwit A, Tomonaga M and
Peterson LC: International Council for Standardization In
Hematology: ICSH guidelines for the standardization of bone marrow
specimens and reports. Int J Lab Hematol. 30:349–364. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mellins ED, Macubas C and Grom AA:
Pathogenesis of systemic juvenile idiopathic arthritis: Some
answers, more questions. Nat Rev Rheumatol. 7:416–426. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hadchouel M, Prieur AM and Griscelli C:
Acute hemorrhagic, hepatic, and neurologic manifestations in
juvenile rheumatoid arthritis: possible relationship to drugs or
infection. J Pediatr. 106:561–566. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grom AA: Natural killer cell dysfunction:
A common pathway in systemic-onset juvenile rheumatoid arthritis,
macrophage activation syndrome, and hemophagocytic
lymphohistiocytosis? Arthritis Rheum. 50:689–698. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stéphan J, Koné-Paut I, Galambrun C, Mouy
R, Bader-Meunier B and Prieur A: Reactive haemophagocytic syndrome
in children with inflammatory disorders. A retrospective study of
24 patients. Rheumatology (Oxford). 40:1285–1292. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pringe A, Trail L, Ruperto N, Buoncompagni
A, Loy A, Breda L, Martini A and Ravelli A: Macrophage activation
syndrome in juvenile systemic lupus erythematosus: An
under-recognized complication? Lupus. 16:587–592. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Parodi A, Davì S, Pringe AB, Pistorio A,
Ruperto N, Magni-Manzoni S, Miettunen P, Bader-Meunier B, Espada G,
Sterba G, et al: Macrophage activation syndrome in juvenile
systemic lupus erythematosus: A multinational multicenter study of
thirty-eight patients. Arthritis Rheum. 60:3388–3399. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grom A: Macrophage activation syndrome and
reactive hemophagocytic lymphohistiocytosis: The same entities?
Curr Opin Rheumatol. 15:587–590. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Janka G: Hemophagocytic syndromes. Blood
Rev. 21:245–253. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sawhney S, Woo P and Murray KJ: Macrophage
activation syndrome: A potentially fatal complication of rheumatic
disorders. Arch Dis Child. 85:421–426. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moradinejad MH and Ziaee V: The incidence
of macrophage activation syndrome in children with rheumatic
disorders. Minerva Pediatr. 63:459–466. 2011.PubMed/NCBI
|
